Rapporto sull’analisi delle dimensioni del mercato e dell’analisi delle quote del mercato dei reagenti diagnostici per anticorpi monoclonali | Previsioni 2031

  • Report Code : TIPRE00027682
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 168
Buy Now

Il mercato globale dei reagenti diagnostici per anticorpi monoclonali è stato valutato 7.654,06 milioni di dollari nel 2021; si stima che crescerà a un CAGR del 13,5% dal 2022 al 2028.

Gli anticorpi monoclonali (mAb) sono importanti reagenti diagnostici utilizzati nella ricerca biomedica; ricerca microbiologica; nella diagnosi di epatite, AIDS, influenza, herpes simplex, infezioni da clamidia; e nel trattamento delle infezioni e del cancro. Gli anticorpi monoclonali diretti contro singoli epitopi sono altamente specifici, omogenei e possono essere prodotti in quantità illimitate. La tecnologia degli anticorpi monoclonali derivati da ibridomi o clonati battericamente ha consentito la produzione di massa di sonde altamente specifiche per siti antigenici, siano essi su ormoni, enzimi, recettori o prodotti microbici. I principali fattori che guidano la crescita di questo mercato includono la crescente prevalenza del cancro e di altre malattie croniche, la presenza di una forte pipeline di farmaci in fase di sperimentazione e gli estesi sforzi di ricerca e sviluppo per sviluppare nuove terapie.

Il rapporto offre approfondimenti e analisi approfondite del mercato globale dei reagenti diagnostici per anticorpi monoclonali, sottolineando vari parametri, tra cui tendenze del mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo dei principali attori del mercato globale. Include anche l'impatto della pandemia COVID-19 sul mercato in tutte le regioni.

L'impatto complessivo della pandemia COVID-19 sul mercato dei reagenti diagnostici per anticorpi monoclonali è stato positivo; quindi, il mercato continua a guadagnare terreno e si prevede che crescerà nei prossimi anni. Celltrion Group ha annunciato che il Ministero coreano per la sicurezza alimentare e farmaceutica (MFDS) ha approvato regdanvimab (CT-P59), un anticorpo monoclonale per il trattamento del COVID-19 per l'uso prolungato in pazienti anziani di età pari o superiore a 50 anni o con almeno una condizione medica di base come obesità, malattia cardiovascolare, malattia polmonare cronica, diabete, malattia renale cronica, malattia epatica cronica e pazienti con agenti immunosoppressori con sintomi lievi di COVID-19 e pazienti adulti con sintomi moderati di COVID-19 . Inoltre, la terapia con anticorpi monoclonali, utilizzata con successo in altri paesi per trattare i pazienti affetti da COVID-19 con sintomi lievi o moderati, è stata ora approvata dal Drugs Controller General of India (DCGI) per l'uso in India.

< h3>Approfondimenti strategici

Approfondimenti basati sulla geografia

In base all'area geografica, il mercato globale dei reagenti diagnostici per anticorpi monoclonali è segmentato in Nord America (Stati Uniti, Canada e Messico), Europa (Francia , Germania, Regno Unito, Spagna, Russia, Italia e resto d'Europa), Asia Pacifico (Cina, India, Giappone, Australia, Corea del Sud, Kazakistan e resto dell'APAC), Medio Oriente e altri paesi. Africa (Arabia Saudita, Emirati Arabi Uniti, Sud Africa e resto del Medio Oriente e dell'Africa) e Sud e Africa. America centrale (Brasile, Argentina e il resto dell'America centrale e meridionale).

Regioni redditizie per il mercato dei reagenti diagnostici per anticorpi monoclonali

Approfondimenti di mercato< /h3>

Ampli sforzi di ricerca e sviluppo per sviluppare nuove terapie

Le numerose applicazioni dei mAbs implicano la prevenzione, la diagnosi e il trattamento delle malattie. L'applicazione dei mAbs nella diagnosi è la più avanzata, in particolare per i test eseguiti sui fluidi corporei come l'urina e il sangue. Inoltre, l'applicazione diagnostica dei mAbs include tecniche come ELISA, western blot, immunoblot blot, citometria a flusso, immunoistochimica, test radioimmunologico e microscopia elettronica. Inoltre, i mAb destinati ad applicazioni diagnostiche possono rilevare antigeni e anticorpi contro malattie virali e fungine del bestiame e malattie parassitarie.

Inoltre, i mAb sono reagenti apprezzati destinati ad applicazioni abbondanti grazie alla loro selettività, elevata affinità di legame e immunogenicità/bassa tossicità; I mAb sono più adatti per la ricerca clinica, ambientale ed elementare. Le applicazioni diagnostiche dei mAb includono anche dispositivi medici, test in vitro e imaging medico.

Inoltre, l'utilità dei mAb si è ampliata per comprendere una serie di malattie contribuendo allo sviluppo di nuovi trattamenti immunoterapici. Ad esempio, le terapie contro il cancro hanno beneficiato della ricerca con i mAb, molto probabilmente per lo sviluppo di RituximAb, dimostrandosi un trattamento efficace per molti tumori. Inoltre, molti mAb sono ora riconosciuti dalla Food and Drug Administration (FDA) statunitense come sicuri per l’utilizzo nelle terapie commerciali. Si prevede che tali fattori sopra menzionati contribuiranno alla crescita del mercato dei reagenti diagnostici per anticorpi monoclonali durante il periodo di previsione.

Approfondimenti basati su test

Sulla base di test, il mercato globale dei reagenti diagnostici per anticorpi monoclonali è segmentato in metodo di chemiluminescenza a sandwich con doppio antigene, test immunoassorbente legato a enzimi, test immunoblot ricombinante e test di filtrazione dot-immunogold. Nel 2021, il segmento dei test immunoassorbenti legati all'enzima ha rappresentato la quota di mercato maggiore e si prevede che registrerà il CAGR più elevato dal 2022 al 2028.

Mercato globale dei reagenti diagnostici per anticorpi monoclonali, in base ai test - 2021 e 2028

Approfondimenti basati sull'applicazione

In base all'applicazione, il mercato globale dei reagenti diagnostici per anticorpi monoclonali è segmentato in diagnosi ormonale, monitoraggio dei tumori, rilevamento di virus e altre applicazioni. Il segmento del monitoraggio dei tumori ha detenuto la quota di mercato maggiore nel 2021 e si prevede che registrerà il CAGR più elevato durante il periodo di previsione.

Gli attori del mercato globale dei reagenti diagnostici per anticorpi monoclonali stanno adottando strategie organiche, compreso il lancio del prodotto e espansione, per espandere la propria presenza e il portafoglio prodotti in tutto il mondo e soddisfare la crescente domanda di prodotti. Alcuni dei principali attori che operano sul mercato sono BioGenex; Bio-Rad Laboratories, Inc.; Biocare medico, LLC; Celltrion Healthcare Co., Ltd.; Diagnostica creativa; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; AptoGen; e Abcam plc.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are monoclonal antibody diagnostic reagent?

Monoclonal antibodies (mAb) are important diagnostic reagents that are being used in biomedical research, microbiological research in diagnosis of Hepatitis, AIDs, influenza, herpes simplex, chlamydia infections and in treatment of infections and cancer. The monoclonal antibodies being directed against single epitopes are highly specific, homogeneous and can be produced in unlimited quantities. The hybridoma-derived or bacterially cloned monoclonal antibody technology has enabled the mass production of highly specific probes for antigenic sites, whether on hormones, enzymes, receptors, or microbial products.

What are the driving factors for the global monoclonal antibody diagnostic reagent market across the world?

Rising prevalence of cancer and other chronic diseases, extensive R&D efforts to develop novel therapies, and presence of strong pipeline of drugs under trial are the major factors contributing to the growth of the monoclonal antibody diagnostic reagent industry.

Who are the major players in the monoclonal antibody diagnostic reagent market across the globe?

The monoclonal antibody diagnostic reagent market majorly consists of the players, such as BioGenex; Bio-Rad Laboratories, Inc.; Biocare Medical, LLC; Celltrion Healthcare Co., Ltd.; Creative Diagnostics; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; Apto-Gen; and Abcam plc.

What is the market CAGR value of the monoclonal antibody diagnostic reagent market during the forecast period?

The CAGR value of the monoclonal antibody diagnostic reagent market during the forecasted period of 2022-2028 is 13.5%

What is the estimated monoclonal antibody diagnostic reagent market size in 2022?

The monoclonal antibody diagnostic reagent market is estimated to be valued at US$ 8,642.00 million in 2022.

What are the growth estimates for the monoclonal antibody diagnostic reagent market till 2028?

The monoclonal antibody diagnostic reagent market is expected to be valued at US$ 18,507.20 million in 2028.

Which segment by tests led the monoclonal antibody diagnostic reagent market?

The enzyme-linked immunosorbent assay segment held the largest share of the market in the global monoclonal antibody diagnostic reagent market contributing a market share of 37.89% in 2021.

Which region is projected to be the fastest-growing region in the global monoclonal antibody diagnostic reagent market?

The Asia Pacific is expected to be the fastest-growing region in the monoclonal antibody diagnostic reagent market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and chronic diseases in these regions will show promising growth in the monoclonal antibody diagnostic reagent market.

The List of Companies - Monoclonal Antibody Diagnostic Reagent Market

  1. BioGenex
  2. Bio-Rad Laboratories, Inc.
  3. Biocare Medical, LLC
  4. Celltrion Healthcare Co., Ltd.
  5. Creative Diagnostics
  6. GenWay Biotech
  7. Thermo Fisher Scientific Inc.
  8. ABclonal, Inc.
  9. Apto-Gen
  10. Abcam plc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports